Rights and permissions
About this article
Cite this article
Controlled-release etodolac cost saving in osteoarthritis. Pharmacoecon. Outcomes News 123, 7 (1997). https://doi.org/10.1007/BF03271850
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03271850